Work

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Year: 2020
Type: article
Study design: Observational Study
Abstract: Classification of breast cancer into intrinsic subtypes has clinical and epidemiologic importance. To examine accuracy of immunohistochemistry (IHC)-based methods for identifying intrinsic subtypes, a three-biomarker IHC panel was compared to the clinical record and RNA-based intrinsic (PAM50) subtypes.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W4301943597
FWCI:
Cites:
Cited by:
Related to: 10